Overview

Long Term Effects of Raloxifene Treatment on Bone Quality

Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
This is a cross-sectional study to determine, via iliac crest bone biopsies, the effect of long-term treatment with raloxifene on histomorphometry and bone quality in patients who participated in the Continuing Outcomes Relevant to Evista Study.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Raloxifene Hydrochloride